Clinical Partnerships The company's validated low-dose multi-drug chemotherapy approach with reported survival gains presents opportunities to partner with large oncology networks, hospitals, or CROs for joint trials, referrals, or licensing.

Licensing Opportunities With a small team and mid-market revenue, there is potential to monetize the methodology via licensing, co-development agreements, or white-label deployment with mid-to-large cancer care providers to accelerate scale.

Tech Modernization The tech stack shows reliance on legacy Adobe ColdFusion alongside modern CDN and analytics tools; offer IT modernization, data integration, and secure cloud hosting to support regulated data capture and regulatory reporting as the company grows.

Data-Driven Growth Expand data capabilities by augmenting Google Analytics usage with outcome tracking dashboards and partner data sharing to support evidence generation and market access discussions.

Security and Compliance Strengthen data security and regulatory compliance (HIPAA) with vendor risk management and compliant hosting to enable partnerships with larger healthcare networks and build patient trust.